Heart patients who participate in cardiac rehab programs typically do well during enrollment but tend to revert to unhealthy lifestyles once the formal gym-based regimens end.
Mar 15, 2018
0
5
Although erectile dysfunction (ED) has been shown to be an early warning sign for heart disease, some physicians – and patients – still think of it as just as a natural part of "old age." But now an international ...
Jul 25, 2012
0
0
In 2009, Minneapolis Heart Institute Foundation (MHIF), along with Allina Health, New Ulm Medical Center (NUMC) and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart ...
Mar 14, 2016
0
17
Implantable devices and wearables like smart-watches enable continuous or near-continuous monitoring of cardiac rhythm. This leads to detection of short arrhythmias in many people, especially elderly persons with cardiovascular ...
Jun 28, 2023
0
4
After decades of decline, fatal coronary heart disease may rise again unless Americans modify three major risk factors: smoking, drinking, and obesity.
Aug 3, 2023
0
25
Researchers at Boston University School of Medicine (BUSM) have been part of a multicenter observational study called TRACS (Transthyretin Amyloidosis Cardiac Study) to help determine the health significance of a particular ...
Aug 13, 2012
0
0
Although use of hospice services is increasing dramatically, a study led by Regenstrief Institute investigator Kathleen T. Unroe, M.D., MHA, an assistant research professor of medicine at the Indiana University School of ...
Jun 25, 2012
0
0
Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular Genetics trial presented in ...
Sep 4, 2019
0
1
Three years after the COVID-19 pandemic exposed racial and ethnic health disparities nationwide, those disparities continue to exist in American communities of color.
Feb 23, 2023
0
8
A re-analysis of the data from a pivotal study of rosiglitazone found no increased risk of cardiovascular events associated with the controversial diabetes drug, according to researchers at the Duke Clinical Research Institute ...
Jun 7, 2013
0
0
